Skip to content

Use of a Mobile Health System (PD-Buddy) Application to Support Patients on Peritoneal Dialysis– A Feasibility Randomised Controlled Trial

A pilot randomised control trial to assess feasibility of comparing an electronic patient monitoring portal versus usual care in patients on peritoneal dialysis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000482369
Enrollment
44
Registered
2026-04-17
Start date
2022-04-08
Completion date
2022-09-14
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People receiving peritoneal dialysis (PD) are expected to record considerable clinical and dialysis-related information at home. This study aimed to assess the feasibility and clinical outcomes of a novel smartphone application (App), PD-Buddy, developed to facilitate timely and accurate PD data collection and sharing with the PD healthcare team.

Interventions

Use of a mobile application - PD BUDDY - by 1. Patients - to record patient level observations at daily intervals (including weight, blood pressure, oedema) symptoms (including shortness of breath, exercise tolerance), and therapy level covariates (type of peritoneal dialysis fluid, number of exchanges, and ultrafiltration). Access for duration of study - 6 months. Enrolled participants are provisioned by an admin and download the app from their respective app store. 2. Clinicians - to monito

Use of a mobile application - PD BUDDY - by 1. Patients - to record patient level observations at daily intervals (including weight, blood pressure, oedema) symptoms (including shortness of breath, exercise tolerance), and therapy level covariates (type of peritoneal dialysis fluid, number of exchanges, and ultrafiltration). Access for duration of study - 6 months. Enrolled participants are provisioned by an admin and download the app from their respective app store. 2. Clinicians - to monitor patient observations, symptoms and therapy via a web portal remotely thrice weekly. No application specific alerts.

Sponsors

Princess Alexandra Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults with kidney failure who were receiving PD or commenced PD at Princess Alexandra Hospital between 1 January 2022 and 31 August 2023. Patients must own a mobile device, Patients need to be proficient in English (patient and/or carer), Patient's need to comply with the study's technological requirements.

Exclusion criteria

None

Outcome results

None listed

Source: ANZCTR · Data processed: May 1, 2026